Short-term course of 1,25(OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis

Calcified Tissue International

Volumn 49, Issue 3, 1991, Pages 168-173

  Geusens, Piet ^a   Vanderschueren, Dirk ^a   Verstraeten, Anne ^a   Dequeker, Jan ^a   Devos, Paul ^a   Bouillon, Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; HYDROXYPROLINE; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; BONE DEVELOPMENT; BONE RESORPTION; CALCITRIOL; CALCIUM; FEMALE; HUMAN; HYDROXYPROLINE; MIDDLE AGE; OSTEOARTHRITIS; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; OSTEOPOROSIS; PARATHYROID HORMONES; TIME FACTORS; VITAMIN D;

EID: 0025954855     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/BF02556112     Document Type: Article

References (52)

1. 1 alpha, 25-dihydroxyvitamin D3 receptors in cultured rat osteoblast-like cells. Glucocorticoid treatment increases receptor content
2. 1,25-dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells
3. Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis
4. 1,25-dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women
5. 1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture
6. The role of vitamin D metabolites on bone resorption
7. 1,25-Dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone
8. Coherence treatment of osteoporosis
9. Use of calciferol and its metabolites and analogues in osteoporosis
10. Involutional osteoporosis and ADFR treatment: a controlled pilot study
11. A post mortem study of the hip joint
12. Osteoarthritis of the hip: the patient behind the disease
13. Osteoarthritis of the hip joint and osteoporosis
14. Osteoarthritis of the hip and fractures of the proximal end of the femur
15. Bone density, osteoarthritis of the hip and fracture of the upper end of the femur
16. Osteoarthritis at the hand skeleton in primary osteoarthrosis of the hip and in normal controls
17. Cortical bone remodeling and bone mass in primary osteoarthrosis of the hip
18. Bone mass in osteoarthrosis, measured in vivo by photon absorptiometry
19. Trabecular pattern of the upper end of the femur in primary osteoarthrosis and in symptomatic osteoporosis
20. Bone mass in primary coxarthrosis
21. Bone density in generalized osteoarthritis
22. Physical and histomorphological characteristics of iliac crest bone, according to osteoarthritis grade at the hand joints
23. Osteoporosis and osteoarthritis (osteoarthrosis): anthropometric distinctions
24. Age-related blood changes in hip osteoarthritis patients: a possible indicator of bone quality
25. Serum bone Gla protein (osteocalcin) and other markers of bone mineral metabolism in postmenopausal osteoporosis and osteoarthritis
26. Dynamics of growth hormone secretion in patienets with osteoporosis and in patients with osteoarthrosis
27. Histomorphometric changes in the trabecular structure of a selected stress region in the femur in patients with osteoarthritis and fracture of the femoral neck
28. Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis
29. Parathyroid function in patients with hyper- or hypothyroidism
30. Measurement of 25 hydroxyvitamin D3 in serum
31. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma
32. Increased levels of osteocalcin (serum bone Gla-protein) in rheumatoid arthritis
33. Zur routinemängen Bestimmung von Hydroxyproline in Harn
34. The quantitative determination of glycosaminoglycans in urine with Alcian Blue 8GX
35. Age-, sex- and menopause-related changes of vertebral and peripheral bone: population study using dual and single photon absorptiometry and radiogrammetry
36. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients
37. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers
38. Phenotype-associated changes in the effect of 1,25-dehydroxyvitamin D3 on alkaline phosphatase and bone gla protein of rat osteoblastic cells
39. Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells
40. Evidence for alteration of the vitamin D-endocrine system in obese subjects
41. Evidence for alteration of the vitamin D-endocrine system in blacks
42. Calcitriol treatment is not effective in postmenopausal osteoporosis
43. Treatment of postmenopausal osteoporosis with calcitriol
44. 1,25-dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis
45. Effect of long-term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis
46. Normal and pathological remodeling of human trabecular bone: three-dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease
47. Relation between bone mass and muscle weight
48. The minimum effective dose of estrogen for prevention of postmenopausal bone loss